paper-with-me

홈 › Papers

HIV-1 virus cycle replication: a review of RNA polymerase II transcription, alternative splicing and protein synthesis

2019-03-12 · Miguel Ramos Pascual

HIV virus replication is a time-related process that includes several stages. Focusing on the core steps, RNA polymerase II transcripts in an early stage pre-mRNA containing regulator proteins (i.e nef,tat,rev,vif,vpr,vpu), which are completely spliced by the spliceosome complex (0.9kb and 1.8kb) and exported to the ribosome for protein synthesis. These splicing and export processes are regulated by tat protein, which binds on Trans-activation response (TAR) element, and by rev protein, which binds to the Rev-responsive Element (RRE). As long as these regulators are synthesized, splicing is progressively inhibited (from 4.0kb to 9.0kb) and mRNAs are translated into structural and enzymatic proteins (env, gag-pol). During this RNAPII scanning and splicing, around 40 different multi-cystronic mRNA have been produced. Long-read sequencing has been applied to the HIV-1 virus genome (type HXB2CG) with the HIV.pro software, a fortran 90 code for simulating the virus replication cycle, specially RNAPII transcription, exon/intron splicing and ribosome protein synthesis, including the frameshift at gag/pol gene and the ribosome pause at env gene. All HIV-1 virus proteins have been identified as far as other ORFs. As observed, tat/rev protein regulators have different length depending on the splicing cleavage site: tat protein varies from 224aa to a final state of 72aa, whereas rev protein from 25aa to 27aa, with a maximum of 119aa. Furthermore, several ORFs coding for small polypeptides sPEP (less than 10 amino acids) and for other unidentified proteins have been localised with unknown functionality. The detailed analysis of the HIV virus replication and the virus proteomics are important for identifying which antigens are presented by macrophages to CD4 cells, for localizing reactive epitopes or for creating transfer vectors to develop new HIV vaccines and effective therapies.

📄 PDF Abstract BibTeX arXiv:1903.05067

Code (0)

등록된 구현이 없습니다.

Tasks

TAR

Similar Papers 제목 키워드 기반

Therapeutic Interfering Particles Exploiting Viral Replication and Assembly Mechanisms Show Promising Performance: A Modelling Study

2021-08-04 · Farzad Fatehi, Richard J. Bingham, Pierre-Philippe Dechant, Peter G. Stockley 외

Defective interfering particles arise spontaneously during a viral infection as mutants lacking essential parts of the viral genome. Their ability to replicate in the presence of the wild-type (WT) virus (at the expense …

Coronavirus SARS-CoV-2: Analysis of subgenomic mRNA transcription, 3CLpro and PL2pro protease cleavage sites and protein synthesis

2020-04-02 · Miguel Ramos Pascual

Coronaviruses have recently caused world-wide severe outbreaks: SARS (Severe Acute Respiratory Syndrome) in 2002 and MERS (Middle-East Respiratory Syndrome) in 2012. At the end of 2019, a new coronavirus outbreak appeare…

Diagnostic

Tetrameric UvrD helicase is located at the E. coli replisome due to frequent replication blocks

2021-02-22 · Adam J. M Wollman, Aisha H. Syeda, Andrew Leech, Colin Guy 외

DNA replication in all organisms must overcome nucleoprotein blocks to complete genome duplication. Accessory replicative helicases in Escherichia coli, Rep and UvrD, help replication machinery overcome blocks by removin…

Transcription-translation machinery -- an autocatalytic network coupling all cellular cycles and generating a plethora of growth laws

2021-03-29 · Anjan Roy, Dotan Goberman, Rami Pugatch

Recently discovered simple quantitative relations, known as bacterial growth laws, hint on the existence of simple underlying principles at the heart of bacterial growth. In this work, we provide a unifying picture on ho…

AllTranslation

The Complexity of Molecular Interactions and Bindings between Cyclic Peptide and Inhibit Polymerase A and B1 (PAC-PB1N) H1N1

2015-10-27

The influenza/H1N1 virus has caused hazard in the public health of many countries. Hence, existing influenza drugs could not cope with H1N1 infection due to the high mutation rate of the virus. In this respect, new metho…